Rachel Hagan speaks to some of researchers behind the push for a full HIV vaccine – whose trial had to be saved after the US slashed its grant – about the cost of the delay, and lays out the warnings it provides for the current rollout of the ‘transformational’ preventative jab lenacapavir
Notifications can be managed in browser preferences.
Swipe for next article
Rachel Hagan speaks to some of researchers behind the push for a full HIV vaccine – whose trial had to be saved after the US slashed its grant – about the cost of the delay, and lays out the warnings it provides for the current rollout of the ‘transformational’ preventative jab lenacapavir
Removed from bookmarks
I would like to be emailed about offers, events and updates from The Independent. Read our Privacy notice
Jeffrey Okoro, of CFK Africa, tells Rachel Hagan that the drug lenacapavir can be transformative, but Kenya’s rollout is not yet…
A new drug that gives almost complete protection against the virus was to be administered across Africa this year. Now, much of…
The Independent’s Bel Trew tells parliament’s International Development Select Committee that our call to protect funding could…
Aid cuts by the US, and planned cuts by the UK, risk undermining decades of progress and could put millions of lives in danger,…
The figure comes as the UN reports a ‘devastating’ collapse of HIV prevention services around the world
South Africa has been at the forefront of the successful battle to halt the spread of HIV/Aids - until now.
